Long-Jun Gu

1.5k total citations
59 papers, 700 citations indexed

About

Long-Jun Gu is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Long-Jun Gu has authored 59 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 25 papers in Public Health, Environmental and Occupational Health and 16 papers in Molecular Biology. Recurrent topics in Long-Jun Gu's work include Acute Lymphoblastic Leukemia research (25 papers), Acute Myeloid Leukemia Research (21 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Long-Jun Gu is often cited by papers focused on Acute Lymphoblastic Leukemia research (25 papers), Acute Myeloid Leukemia Research (21 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Long-Jun Gu collaborates with scholars based in China, United States and Hong Kong. Long-Jun Gu's co-authors include Sai‐Juan Chen, Hui-liang Xue, Zhixiang Shen, Qiuhua Huang, Carlos Caldas, MH Sham, Li Chong Chan, Leanne M. Wiedemann, Chen Zhu and Chi Wai Eric So and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Blood.

In The Last Decade

Long-Jun Gu

57 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long-Jun Gu China 11 401 240 184 85 70 59 700
Ashis Mukhopadhyay India 13 204 0.5× 118 0.5× 72 0.4× 188 2.2× 44 0.6× 61 555
Jiali Si United States 8 554 1.4× 197 0.8× 41 0.2× 67 0.8× 13 0.2× 8 752
ZY Wang China 9 327 0.8× 251 1.0× 51 0.3× 65 0.8× 10 0.1× 14 563
Huyong Zheng China 15 617 1.5× 66 0.3× 69 0.4× 176 2.1× 28 0.4× 57 826
G Deb Italy 11 210 0.5× 130 0.5× 123 0.7× 152 1.8× 41 0.6× 16 640
Chiho Ono Japan 14 169 0.4× 79 0.3× 47 0.3× 199 2.3× 37 0.5× 29 522
RP Jr Warrell United States 10 1.2k 2.9× 854 3.6× 183 1.0× 113 1.3× 19 0.3× 15 1.4k
Louise F. Momparler Canada 21 1.1k 2.6× 338 1.4× 109 0.6× 153 1.8× 24 0.3× 36 1.3k
Ying Lu China 15 222 0.6× 127 0.5× 47 0.3× 218 2.6× 13 0.2× 58 538
Stephan Lobitz Germany 16 435 1.1× 214 0.9× 43 0.2× 85 1.0× 99 1.4× 34 822

Countries citing papers authored by Long-Jun Gu

Since Specialization
Citations

This map shows the geographic impact of Long-Jun Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long-Jun Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long-Jun Gu more than expected).

Fields of papers citing papers by Long-Jun Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long-Jun Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long-Jun Gu. The network helps show where Long-Jun Gu may publish in the future.

Co-authorship network of co-authors of Long-Jun Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Long-Jun Gu. A scholar is included among the top collaborators of Long-Jun Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long-Jun Gu. Long-Jun Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Long-Jun, et al.. (2024). The Inhibition of Reactive Oxygen Species Modulator 1 Attenuates Sevoflurane-Induced Neural Injury via Reducing Apoptosis and Oxidative Stress. Journal of Molecular Neuroscience. 74(4). 97–97. 2 indexed citations
2.
Wang, Jibo, Haowen Qiao, Zhenyan Wang, et al.. (2023). Rational Design and Acoustic Assembly of Human Cerebral Cortex‐Like Microtissues from hiPSC‐Derived Neural Progenitors and Neurons. Advanced Materials. 35(32). e2210631–e2210631. 14 indexed citations
3.
Wan, Xinyu, Xiaomin Yang, Fan Yang, et al.. (2021). Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse. Cancer Research and Treatment. 54(3). 917–925. 10 indexed citations
4.
Chen, Xiaoxiao, Yanjing Tang, Jing Chen, et al.. (2019). Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia. Frontiers of Medicine. 13(3). 378–387. 14 indexed citations
5.
Liu, Yang, Lixia Ding, Jianwei Liang, et al.. (2018). Relatively favorable prognosis for MLL‐rearranged childhood acute leukemia with reciprocal translocations. Pediatric Blood & Cancer. 65(10). e27266–e27266. 4 indexed citations
6.
Zhao, Jie, Jianwei Liang, Hui-liang Xue, et al.. (2018). The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia. Leukemia. 33(6). 1387–1399. 46 indexed citations
7.
Shen, Shuhong, Jiaoyang Cai, Jing Chen, et al.. (2018). Long‐term results of the risk‐stratified treatment of childhood acute lymphoblastic leukemia in China. Hematological Oncology. 36(4). 679–688. 22 indexed citations
8.
He, Yingyi, Benshang Li, Jing Chen, et al.. (2011). Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(2). 159–163. 4 indexed citations
9.
Tang, Jingyan, Yin Liu, Jing Chen, et al.. (2011). Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China. International Journal of Hematology. 93(5). 610–617. 7 indexed citations
10.
Chen, Jing, et al.. (2010). Outcome of Chinese children with unrelated donor hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 55(7). 1386–1392. 2 indexed citations
11.
Li, Ben-Shang, et al.. (2010). [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].. PubMed. 18(3). 559–63. 1 indexed citations
12.
Tang, Jingyan, Long-Jun Gu, Hui-liang Xue, et al.. (2009). [Report on induction efficacy of protocol ALL-2005 and middle term follow-up of 158 cases of childhood acute lymphoblastic leukemia].. PubMed. 30(5). 289–93. 3 indexed citations
13.
Gu, Long-Jun, et al.. (2008). Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells. Chinese Medical Journal. 121(5). 463–468. 8 indexed citations
14.
Tang, Jingyan, Jing Chen, Min Xu, et al.. (2006). [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].. PubMed. 44(10). 770–3. 3 indexed citations
15.
Tang, Jingyan, et al.. (2005). [Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia].. PubMed. 43(7). 490–3. 5 indexed citations
16.
Chen, Y-H., Yihuan Wang, Gary Kunkel, et al.. (2005). Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus. Clinical Rheumatology. 24(5). 464–468. 14 indexed citations
17.
Liang, Aibin, Li Li, Xiaotian Xie, et al.. (2005). [Preliminary study of VEGF and its receptor expression on childhood acute lymphoblastic leukemia and its relativity to clinical manifestations].. PubMed. 26(8). 489–92. 1 indexed citations
18.
Chen, Jing, Long-Jun Gu, Huijun Zhao, et al.. (2003). [Application of CD34+ autologous peripheral progenitor cell transplant in the treatment of children with refractory SLE].. PubMed. 41(6). 426–9. 2 indexed citations
19.
Tang, Jingyan, Hui-liang Xue, Ci Pan, et al.. (2003). A homoharringtonine‐based regimen for childhood acute myelogenous leukemia. Medical and Pediatric Oncology. 41(1). 70–72. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashis Mukhopadhyay Breakdown of academic impact, for papers by Jiali Si Breakdown of academic impact, for papers by ZY Wang Breakdown of academic impact, for papers by Huyong Zheng Breakdown of academic impact, for papers by G Deb Breakdown of academic impact, for papers by Chiho Ono Breakdown of academic impact, for papers by RP Jr Warrell Breakdown of academic impact, for papers by Louise F. Momparler Breakdown of academic impact, for papers by Ying Lu Breakdown of academic impact, for papers by Stephan Lobitz
Rankless by CCL
2026